Clinical trial
KULeuven Intensive Insulin Therapy Study in Medical Intensive Care Patients
NCT00115479 · KU Leuven, Other · Completed
Key facts
| NCT number | NCT00115479 |
|---|---|
| Title | KULeuven Intensive Insulin Therapy Study in Medical Intensive Care Patients |
| Official title | KULeuven Intensive Insulin Therapy Study in Medical Intensive Care Patients |
| Lead sponsor | KU Leuven, Other |
| Collaborators | Fund for Scientific Research, Flanders, Belgium Novo Nordisk A/S Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Critical Illness |
| Intervention type | Drug |
| Interventions | intensive insulin therapy to maintain normoglycemia |
| Enrollment | 1,200 |
| Start date | Mar 1, 2002 |
| Completion | Jun 1, 2005 |
| First posted | Jun 23, 2005 |
| Last update posted | May 4, 2006 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: